JNPMEDI Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
JNPMEDI Inc. - overview
Established
2020
Location
Incheon, -, South Korea
Primary Industry
Healthcare IT
About
Founded in 2020, and based in Seoul, South Korea, JNPMEDI Inc. is a pharmaceuticals company that operates a cloud-based data platform that digitalizes clinical research and trial operations. Jeon Jeong-ho is the CEO of the company. In August 2025, JNPMEDI Inc.
raised an undisclosed amount in venture funding from new investors Naver and TBT Partners. The company operates Maven CDMS™, a medical data platform monitoring solution that collects, monitors, and analyzes medical data for clinical trials based on digital technologies such as blockchain and cloud technology. The enterprise's maven clinical cloud solutions include maven coder, maven EDC, maven builder, maven RTSM, maven auditor, and maven trigger. The firm provides clinical data management solutions, clinical trial management solutions, and professional services.
JNPMEDI also offers management consulting, digital transformation strategy, cutting-edge tech development, clinical operations, and pharmaceuticals. The organization generates revenue through its subscription plans that include maven standard, maven professional, and maven extensive.
Current Investors
AJU IB Investment, Kakao Ventures, Murex Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Pharmaceutical Research & Development, Medical Software
Website
www.jnpmedi.com
Verticals
Blockchain, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
JNPMEDI Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.